Scholars Central

OpinionPublished 15 Dec 2021

Kinase Activity in Invasive Tumors

Authors: David Richards

British Biomedical Bulletin

Volume 9 · Issue 4 · Pages 03

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The ability of oncogenic Met to facilitate chemically induced transformation of a human osteogenic sarcoma cell line led to the discovery of the MET proto-oncogene. Met, the gene's normal product, is an unique receptor tyrosine kinase that can be separated from most others by its biosynthesis and structural characteristics. This transmembrane protein is made up of a single-chain precursor that is cleaved at a basic amino acid position by intracellular proteolysis, resulting in a disulfide-linked heterodimer. It has a multipurpose docking site in its C-terminal intracellular region that interacts to numerous signaling molecules. These characteristics identify the Met receptor tyrosine kinase family, which includes Met, Ron, and c-Sea, the latter of which may be the chicken ortholog of Ron. HGF, also known as scatter factor, is the Met receptor's ligand. HGF was shown to be a mitogenic factor for liver cells as well as a scattering/motility factor for epithelial cells produced from fibroblasts.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in British Biomedical Bulletin.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBritish Biomedical Bulletin
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “David Richards”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels